Oct 22, 2026 07:06AM
Oct 9, 2026 07:05AM
Oct 8, 2026 04:00AM
Oct 8, 2026 04:00AM
Sep 28, 2026 07:31AM
Sep 28, 2026 07:30AM
Sep 18, 2026 05:17AM Citi reiterates buy rating on Biohaven Pharma amid rival's trial pause
Sep 11, 2026 06:59AM
Sep 10, 2026 07:26AM
Aug 26, 2026 07:05AM
Aug 26, 2026 02:36AM
Aug 25, 2026 04:44PM
Aug 25, 2026 04:41PM
Aug 10, 2026 04:02PM Biohaven Reports Recent Business Developments and Second Quarter 2026 Financial Results
Aug 6, 2026 07:00AM
Aug 6, 2026 07:00AM
Jul 27, 2026 07:01AM
Jul 27, 2026 07:00AM
Jul 20, 2026 07:30AM
Jul 9, 2026 05:01PM
Jul 9, 2026 05:00PM Biohaven Announces Scientific Leadership Transitions
Jun 29, 2026 07:31AM
Jun 29, 2026 07:30AM
Jun 1, 2026 07:31AM
Jun 1, 2026 07:30AM
May 27, 2026 07:31AM
May 27, 2026 07:30AM
May 26, 2026 07:31AM Biohaven shares clinical data on epilepsy drug opakalim
May 26, 2026 07:30AM
May 4, 2026 04:02PM
Mar 19, 2026 07:30AM
Mar 19, 2026 07:30AM
Mar 2, 2026 04:05PM
Feb 23, 2026 08:43AM
Jan 12, 2026 11:20AM Biohaven reports early patient data from protein degrader programs
Jan 12, 2026 11:15AM
Jan 7, 2026 07:00AM
Dec 24, 2025 01:00PM
Dec 24, 2025 01:00PM
Dec 11, 2025 07:02AM
Dec 11, 2025 07:00AM
Nov 17, 2025 07:38AM Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $26 at Morgan Stanley
Nov 11, 2025 04:29AM
Nov 10, 2025 06:58AM
Nov 6, 2025 08:37AM
Nov 5, 2025 04:09PM
Nov 5, 2025 03:33PM
Nov 5, 2025 10:00AM
Nov 5, 2025 08:20AM JPMorgan on Biohaven Pharmaceutical (BHVN): 'expect the stock to be under some pressure'
Nov 5, 2025 08:19AM

335,172 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All